- Filed
- May 7, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 195.86M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 194.79M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 190.15M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $82.5M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $48.28M |
| Capex | Q1 2026 · Mar 31, 2026 | $69K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$197.28M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$199.24M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $879.89M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $570.12M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $540.6M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$2.28B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | −$2.09B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $816.37M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $287.97M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.64B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.01B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.24B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $797.75M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.37B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $936.03M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.84 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.88 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.84 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.88 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $163.9M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $106.37M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $126.64M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $111.43M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$105.96M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$104.37M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.94M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $2.64M |
| Revenue | Q1 2026 · Mar 31, 2026 | $194.52M |
| Revenue | Q1 2026 · Mar 31, 2025 | $116.63M |